Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer

Overview of attention for article published in Lung Cancer: Targets and Therapy, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 125)
High Attention Score compared to outputs of the same age (80th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

facebook: 1 Facebook page

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 29 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Dove Medical Press, 07 Sep 2019

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung…